Novavax (NVAX) Other Non Operating Income (2011 - 2026)

Novavax's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 17.59% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $42.4 million (down 42.82% YoY), while the FY2025 annual figure was $40.6 million, changed 0.47% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $11.8 million, up from $9.5 million in the prior quarter.
• The five-year high for Other Non Operating Income was $64.0 million in Q4 2022, with the low at -$34.8 million in Q3 2022.
• The 5-year median for Other Non Operating Income is $9.2 million (2025), against an average of $7.7 million.
• Peak annual rise in Other Non Operating Income reached 14639.86% in 2022, while the deepest fall reached 756.31% in 2022.
• Novavax's Other Non Operating Income stood at $64.0 million in 2022, then sank by 142.07% to -$26.9 million in 2023, then soared by 250.27% to $40.4 million in 2024, then plunged by 76.52% to $9.5 million in 2025, then rose by 24.51% to $11.8 million in 2026.
• Business Quant data shows NVAX's Other Non Operating Income at $11.8 million in Q1 2026, $9.5 million in Q4 2025, and $9.2 million in Q3 2025.